-
Mashup Score: 1Prevalence of advanced fibrosis similar in lean, non-lean MASLD, linked to genetic risk - 9 day(s) ago
WASHINGTON — The risk for advanced fibrosis was similar among patients with lean and non-lean metabolic dysfunction-associated steatotic liver disease and may be associated with genetic risk, according to data at Digestive Disease Week. “There are conflicting studies on the severity of MASLD in patients with a normal BMI, termed lean MASLD, which is estimated to affect up to 10
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 3
WASHINGTON — In a Healio video exclusive, Shirley Paski, MD, discusses highlights from her presentation at Digestive Disease Week, which focused on the importance of screening patients on special diets for nutritional risks and malnutrition. “One thing we often don’t think about when we’re starting patients on a diet for treatment of their GI disease is other factors that
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0Prompt identification of new-onset diabetes may aid early detection of pancreatic cancer - 9 day(s) ago
WASHINGTON — An algorithm that uses electronic health record parameters identified glycemic evidence of new-onset diabetes in real time, which could lead to earlier detection of pancreatic ductal adenocarcinoma, according to researchers. “In retrospective studies, new-onset diabetes has been associated with a higher risk for pancreatic cancer,” Suresh T. Chari, MD, professor
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0Prompt identification of new-onset diabetes may aid early detection of pancreatic cancer - 10 day(s) ago
WASHINGTON — An algorithm that uses electronic health record parameters identified glycemic evidence of new-onset diabetes in real time, which could lead to earlier detection of pancreatic ductal adenocarcinoma, according to researchers. “In retrospective studies, new-onset diabetes has been associated with a higher risk for pancreatic cancer,” Suresh T. Chari, MD, professor
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 5‘No convincing evidence’ linking adult oral antibiotic use, early-onset colorectal cancer - 10 day(s) ago
WASHINGTON — Oral antibiotic use among adult patients was not associated with increased risk for early-onset colorectal cancer, according to data presented at Digestive Disease Week. “The incidence of early-onset colorectal cancer is increasing over the past 3 decades; however, little is known about what may be driving this increase in early-onset CRC,” Jeffrey K. Lee, MD, MPH,
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 2‘Promising’ low-calorie, plant-based diet may improve inflammation, therapy response in UC - 10 day(s) ago
WASHINGTON — “Even at short intervals,” an intermittent low-calorie, plant-based diet may improve inflammation and response to medical therapy among patients with moderately to severely active ulcerative colitis, according to a presenter. “Diet plays a role in IBD inflammation but there are very few clinical trials that examine the impact of diet on UC and, to my
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 6
WASHINGTON — Patients with obesity and metabolic dysfunction-associated fatty liver disease taking glucagon-like peptide-1 receptor agonists had lower risk for all-cause mortality and major cardiovascular events, according to a presenter. “As a future gastroenterologist and current physician advocating for patients with obesity, my research team and I found a critical need to explore
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0‘Encouraging’ data: GLP-1RAs linked to lower risk for cirrhosis in MASLD, type 2 diabetes - 10 day(s) ago
WASHINGTON — Glucagon-like peptide-1 receptor agonists were associated with lower risk for progression to cirrhosis and hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes. “Metabolic dysfunction-associated steatotic liver disease, or MASLD, is a growing cause of cirrhosis and HCC,” Fasiha Kanwal, MD, MSHS,
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 2Bariatric surgery associated with lower mortality, health care cost in patients with MASLD - 10 day(s) ago
WASHINGTON — Bariatric surgery was associated with improved clinical outcomes and more cost-effective health care resource utilization among patients with metabolic dysfunction-associated steatotic liver disease, according to data. “Right now, obesity and the metabolic consequences, which include NAFLD, are continuing to increase every year,” Rayna Patel, MD, a second-year
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 7
WASHINGTON — Parental obesity was associated with a nearly threefold increased risk for metabolic dysfunction-associated steatotic liver disease among offspring in early adulthood, according to data presented at Digestive Disease Week. “Notably, there are no widely adopted screening protocols to identify younger patients with MASLD, as the disease is largely silent and doesn’t
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
The risk for advanced #fibrosis was similar among patients with lean and non-lean #MASLD and may be associated with genetic 🧬 risk, according to data presented by @AjmeraVeeral at #DDW2024 ⬇️ https://t.co/1cUsivzgoa